412 related articles for article (PubMed ID: 26092629)
21. Tea Polyphenols in Promotion of Human Health.
Khan N; Mukhtar H
Nutrients; 2018 Dec; 11(1):. PubMed ID: 30585192
[TBL] [Abstract][Full Text] [Related]
22. Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease.
Jurado-Coronel JC; Ávila-Rodriguez M; Echeverria V; Hidalgo OA; Gonzalez J; Aliev G; Barreto GE
CNS Neurol Disord Drug Targets; 2016; 15(3):292-300. PubMed ID: 26831259
[TBL] [Abstract][Full Text] [Related]
23. Redox chemistry of green tea polyphenols: therapeutic benefits in neurodegenerative diseases.
Hügel HM; Jackson N
Mini Rev Med Chem; 2012 May; 12(5):380-7. PubMed ID: 22303970
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotective Properties of Green Tea (
Malar DS; Prasanth MI; Brimson JM; Sharika R; Sivamaruthi BS; Chaiyasut C; Tencomnao T
Molecules; 2020 Aug; 25(17):. PubMed ID: 32867388
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous Determination of Black Tea-Derived Catechins and Theaflavins in Tissues of Tea Consuming Animals Using Ultra-Performance Liquid-Chromatography Tandem Mass Spectrometry.
Ganguly S; G TK; Mantha S; Panda K
PLoS One; 2016; 11(10):e0163498. PubMed ID: 27695123
[TBL] [Abstract][Full Text] [Related]
26. Green tea polyphenols and their potential role in health and disease.
Afzal M; Safer AM; Menon M
Inflammopharmacology; 2015 Aug; 23(4):151-61. PubMed ID: 26164000
[TBL] [Abstract][Full Text] [Related]
27. Targeting oxidative stress response by green tea polyphenols: clinical implications.
Yiannakopoulou ECh
Free Radic Res; 2013 Sep; 47(9):667-71. PubMed ID: 23805775
[TBL] [Abstract][Full Text] [Related]
28. Having a promising efficacy on type II diabetes, it's definitely a green tea time.
Jiao H; Hu G; Gu D; Ni X
Curr Med Chem; 2015; 22(1):70-9. PubMed ID: 25139278
[TBL] [Abstract][Full Text] [Related]
29. Epigallocatechin-3-Gallate, a Promising Molecule for Parkinson's Disease?
Renaud J; Nabavi SF; Daglia M; Nabavi SM; Martinoli MG
Rejuvenation Res; 2015 Jun; 18(3):257-69. PubMed ID: 25625827
[TBL] [Abstract][Full Text] [Related]
30. Immunomodulatory Effects of Green Tea Polyphenols.
Wang S; Li Z; Ma Y; Liu Y; Lin CC; Li S; Zhan J; Ho CT
Molecules; 2021 Jun; 26(12):. PubMed ID: 34203004
[TBL] [Abstract][Full Text] [Related]
31. Role of green tea catechins in prevention of age-related cognitive decline: Pharmacological targets and clinical perspective.
Farzaei MH; Bahramsoltani R; Abbasabadi Z; Braidy N; Nabavi SM
J Cell Physiol; 2019 Mar; 234(3):2447-2459. PubMed ID: 30187490
[TBL] [Abstract][Full Text] [Related]
32. Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer.
Darvesh AS; Bishayee A
Nutr Cancer; 2013; 65(3):329-44. PubMed ID: 23530632
[TBL] [Abstract][Full Text] [Related]
33. Potential natural antioxidants: adjuvant effect of green tea polyphenols in periodontal infections.
Ramasamy C
Infect Disord Drug Targets; 2015; 15(3):141-52. PubMed ID: 26321324
[TBL] [Abstract][Full Text] [Related]
34. Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys.
Chen M; Wang T; Yue F; Li X; Wang P; Li Y; Chan P; Yu S
Neuroscience; 2015 Feb; 286():383-92. PubMed ID: 25498223
[TBL] [Abstract][Full Text] [Related]
35. Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein.
Teng Y; Zhao J; Ding L; Ding Y; Zhou P
Molecules; 2019 Aug; 24(16):. PubMed ID: 31416122
[TBL] [Abstract][Full Text] [Related]
36. Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate.
Al Hroob AM; Abukhalil MH; Hussein OE; Mahmoud AM
Biomed Pharmacother; 2019 Jan; 109():2155-2172. PubMed ID: 30551473
[TBL] [Abstract][Full Text] [Related]
37. A Review of the Role of Green Tea (
Prasanth MI; Sivamaruthi BS; Chaiyasut C; Tencomnao T
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30813433
[TBL] [Abstract][Full Text] [Related]
38. Black tea polyphenols, theaflavins, prevent cellular DNA damage by inhibiting oxidative stress and suppressing cytochrome P450 1A1 in cell cultures.
Feng Q; Torii Y; Uchida K; Nakamura Y; Hara Y; Osawa T
J Agric Food Chem; 2002 Jan; 50(1):213-20. PubMed ID: 11754570
[TBL] [Abstract][Full Text] [Related]
39. Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease.
Xicota L; Rodriguez-Morato J; Dierssen M; de la Torre R
Curr Drug Targets; 2017; 18(2):174-195. PubMed ID: 26302801
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins.
Dong Z; Ma W; Huang C; Yang CS
Cancer Res; 1997 Oct; 57(19):4414-9. PubMed ID: 9331105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
